Investment Summary |
|
|---|---|
| Date | 2004-08-01 |
| Target | Madrigal Pharmaceuticals |
| Sector | Life Science |
| Investor(s) | Bay City Capital |
| Deal Type | Venture |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 36 of 75 |
| Sector: Life Science M&A | 25 of 54 |
| Type: Venture M&A Deals | 25 of 49 |
| State: Pennsylvania M&A | 1 of 3 |
| Country: United States M&A | 34 of 72 |
| Year: 2004 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-08-01 |
MAP Pharmaceuticals
Mountain View, California, United States MAP Pharmaceuticals, Inc. is a specialty pharmaceutical company developing innovative therapies and inhalation delivery platforms to treat a broad spectrum of respiratory and systemic diseases. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-10-20 |
VNUS Medical Technologies
San Jose, California, United States VNUS Medical Technologies, Inc. is a provider of medical devices for the minimally invasive treatment of venous reflux. |
Sell | - |
